PCI Synthesis Co-Sponsors Third Annual Massachusetts CRO/CMO Symposium
22. April 2014 09:17 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Apr 22, 2014) - PCI Synthesis, a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active...
PCI Synthesis to Pick Up Four 2013 CMO Leadership Awards
10. März 2014 09:17 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Mar 10, 2014) - PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE),...
PCI Synthesis Announces 2014 Trends and Predictions
09. Dezember 2013 11:23 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 9, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 15-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Launches Innovative Product Line: Phosphonic Acids, Used in a Wide Variety of Commercial Applications
05. Dezember 2013 09:46 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 5, 2013) - PCI (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active...
PCI Synthesis Wins Four 2013 CMO Leadership Awards
04. November 2013 09:13 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Nov 4, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE),...
Glenn Killingworth Joins PCI as VP of Business Development
07. Oktober 2013 09:30 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Oct 7, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients...
PCI Synthesis Announces Successful FDA Inspection and Pre-Approval of Two Products
18. September 2013 09:17 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Sep 18, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a custom chemical manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients...
PCI Announces Four New Proprietary APIs During 2012
12. Februar 2013 09:15 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Feb 12, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 14-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active...
PCI Sponsors Second Annual Massachusetts CRO/CMO Symposium
04. Februar 2013 11:59 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Feb 4, 2013) - PCI (www.pcisynthesis.com), a 13-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...
PCI Announces 2013 Trends and Predictions
12. November 2012 08:13 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Nov 12, 2012) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...